{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:28:35Z","timestamp":1770823715748,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":3827,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Using a multiparameter flow cytometry assay enumerating cells positive for CD13, CD14 and CD66 antigens, we determined the asynchronous CD14\/CD66 co\u2010expression in unselected bone marrow and peripheral blood samples with suspected malignant blood disorders. CD14\/CD66 co\u2010expression &gt;5% were found in 131\/691 bone marrow samples. Only 55 of these exhibited an identifiable population in 2\u2010parameter flow cytometry histograms. Of the 55 samples 43 (78%) came from patients with myeloid disorders; e.g. 11 with myelodysplastic syndromes, 15 with chronic myeloproliferative disorders and 17 with acute myeloid leukaemia. Only one of these 17 cases was a <jats:italic>de novo<\/jats:italic> case, while 8 were secondary to another malignant haematological disease and 8 were from the period after cytoreductive therapy. Notably, CD14\/CD66 co\u2010expression patterns were related to disease categories; e.g. in chronic myelomonocytic leukaemia and acute myeloid leukaemia following a dysplastic phase the co\u2010expression displayed two subsets in peripheral blood, low\u2010avidity CD14 and low\u2010avidity CD66, respectively. The latter disease category also exhibited these 2 subsets in bone marrow. In all other cases, the CD14\/CD66 co\u2010expression in bone marrow was heterogeneous. In conclusion, abnormal CD14\/CD66 co\u2010expression might be a valuable parameter in defining asynchronous myelopoiesis in malignant myeloid disorders, especially myeloproliferative disorders and secondary acute myeloid leukemias.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1998.tb01098.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T09:55:19Z","timestamp":1279446919000},"page":"339-346","source":"Crossref","is-referenced-by-count":11,"title":["Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens"],"prefix":"10.1111","volume":"61","author":[{"given":"Ib","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02582.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood.V84.4.1220.1220","article-title":"Prognostic value of immunophenotyping in acute myeloid leukemia","volume":"84","author":"Bradstock K.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V90.8.2863","article-title":"Recent advances in flow cytometry: application to the diagnosis of hematological malignancy","volume":"90","author":"Jennings CD","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110348"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood.V81.11.3043.3043","article-title":"Acute myeloid leukemia M4 with bone marrow eosinophilia and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression","volume":"81","author":"Adriaansen HJ","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2005.bloodjournal8582005"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(84)90001-8"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.3083.3083"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.V67.4.898.898","article-title":"Analysis of leucocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies","volume":"67","author":"Hokland P.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00211.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08301.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.1.63.63"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/44.1.8543780"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb04659.x"},{"key":"e_1_2_1_16_2","first-page":"269","article-title":"Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies","volume":"92","author":"Bonde J.","year":"1996","journal-title":"Br J Haematol"},{"key":"e_1_2_1_17_2","volume-title":"Isolation of mononuclear cells from human blood and bone marrow and identification of leukocyte subsets by multiparameter flow cytometry. Cell Biology","author":"Hokland P.","year":"1998"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.V92.2.574","article-title":"Multiplex RT\u2010PCR for simultaneous screening of 29 translations and chromosomal aberrations in acute leukemia","volume":"92","author":"Pallisgaard N.","year":"1998","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1998.tb01098.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1998.tb01098.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T23:02:19Z","timestamp":1698447739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1998.tb01098.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1111\/j.1600-0609.1998.tb01098.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01098.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}